YATHARTH981.10

Yatharth Hospital & Trauma Care Services Ltd.

· Pharma & Health
₹ CrorePeersMAXHEALTHMEDANTAFORTISVIYASHTHYROCARESUPRIYASTARSPARCMcap ₹9,453 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Returns
Return on Common Equity13.097.979.429.42
Return on Assets11.237.547.467.46
Return on Capital Employed15.829.909.749.74
Return on Invested Capital13.0210.328.468.82
Margins
EBITDA Margin26.8325.0124.2023.26
Operating Margin22.4718.5216.9216.92
Incremental Operating Margin5.9212.62
Pretax Margin23.3919.5118.5216.87
Net Income Margin17.0714.8314.1113.08
FCF Margin-14.38-18.31-9.28-9.28
Additional
Effective Tax Rate27.0123.9823.8222.49
Sustainable Growth Rate13.097.979.429.42
Incremental Operating Margin %5.9212.623.88
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.